Related Experiment Videos
Reye's syndrome in a child on long-term salicylate medication
Forensic Science International
|March 1, 1980
Insights
A four-year-old child developed Reye's syndrome while on long-term salicylate treatment for rheumatoid arthritis. Postmortem findings revealed severe liver and brain damage, mimicking Reye's syndrome.
Area of Science:
- Pediatric Rheumatology
- Toxicology
- Neuropathology
Background:
- Reye's syndrome is a rare but serious condition affecting children and adolescents, often triggered by viral illnesses combined with aspirin use.
- Salicylate medications are commonly prescribed for inflammatory conditions like rheumatoid arthritis in children.
Observation:
- A case report details a four-year-old child with rheumatoid arthritis on long-term salicylate therapy.
- The child presented with symptoms suggestive of Reye's syndrome, including vomiting preceding death.
- The clinical presentation closely resembled Reye's syndrome.
Findings:
- Postmortem examination revealed significant pathological changes.
- Prominent findings included severe fatty degeneration of the liver.
- Renal proximal tubules showed lipid vacuolation, and severe cerebral edema was noted.
Implications:
- This case highlights a potential link between long-term salicylate use and Reye's syndrome in pediatric rheumatoid arthritis patients.
- It underscores the importance of considering salicylate-induced toxicity in children presenting with Reye's-like symptoms.
- Further research may be warranted to explore the risk factors and mechanisms involved in salicylate-associated Reye's syndrome.
Abstract:
A case of Reye's syndrome in a four-year-old child on long-term salicylate medication for rheumatoid arthritis is reported. Severe fatty changes of the liver, lipid vacuolation in the renal proximal tubules, and severe brain oedema were the prominent postmortem findings. Symptoms of a trivial infection and vomiting just before death added to the resemblance of this case to Reye's syndrome.